Skip to main content

Conjupri Side Effects

Generic name: levamlodipine

Medically reviewed by Drugs.com. Last updated on May 11, 2023.

Note: This document contains side effect information about levamlodipine. Some dosage forms listed on this page may not apply to the brand name Conjupri.

Applies to levamlodipine: oral tablet.

Serious side effects of Conjupri

Along with its needed effects, levamlodipine (the active ingredient contained in Conjupri) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking levamlodipine:

Less common

Rare

Incidence not known

Other side effects of Conjupri

Some side effects of levamlodipine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

Rare

For Healthcare Professionals

Applies to levamlodipine: oral tablet.

Other

Very common (10% or more): Edema (10.8%)

Common (1% to 10%): Fatigue

Uncommon (0.1% to 1%): Asthenia, malaise, pain, rigors[Ref]

Cardiovascular

Common (1% to 10%): Palpitation, flushing

Uncommon (0.1% to 1%): Arrhythmia (including ventricular tachycardia and atrial fibrillation), bradycardia, chest pain, peripheral ischemia, syncope, tachycardia, vasculitis, hot flushes[Ref]

Nervous system

Common (1% to 10%): Dizziness, somnolence

Uncommon (0.1% to 1%): Hypoesthesia, neuropathy peripheral, paresthesia, tremor, vertigo, tinnitus

Postmarketing reports: Extrapyramidal disorder[Ref]

Gastrointestinal

Common (1% to 10%): Nausea, abdominal pain

Uncommon (0.1% to 1%): Constipation, dysphagia, diarrhea, flatulence, pancreatitis, vomiting, gingival hyperplasia, dry mouth[Ref]

Hematologic

Uncommon (0.1% to 1%): Leukopenia, purpura, thrombocytopenia[Ref]

Hypersensitivity

Uncommon (0.1% to 1%): Allergic reaction[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Back pain, arthralgia, arthrosis, muscle cramps, myalgia[Ref]

Psychiatric

Uncommon (0.1% to 1%): Sexual dysfunction (male and female), insomnia, nervousness, depression, abnormal dreams, anxiety, depersonalization[Ref]

Genitourinary

Uncommon (0.1% to 1%): Micturition frequency, micturition disorder, nocturia

Postmarketing reports: Gynecomastia[Ref]

Ocular

Uncommon (0.1% to 1%): Abnormal vision, conjunctivitis, diplopia, eye pain[Ref]

Dermatologic

Uncommon (0.1% to 1%): Angioedema, erythema multiforme, pruritus, rash, rash erythematous, rash maculopapular, sweating increased[Ref]

Respiratory

Uncommon (0.1% to 1%): Dyspnea, epistaxis[Ref]

Metabolic

Uncommon (0.1% to 1%): Anorexia, weight gain, weight decrease, hyperglycemia, thirst[Ref]

Hepatic

Jaundice and hepatic enzyme elevations were mostly consistent with cholestasis or hepatitis, and some cases were severe enough to require hospitalization.[Ref]

Postmarketing reports: Jaundice, hepatic enzyme elevations[Ref]

References

1. Product Information. Conjupri (levamlodipine). CSPC Ouyi Pharmaceutical Co, Ltd. 2020.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.